Principles and Predictive Value of Screening. Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity.

Slides:



Advertisements
Similar presentations
Screening and Prevention
Advertisements

Interpreting test results –Sensitivity, Specificity, positive and negative predicted values.
Sample size estimation
Step 3: Critically Appraising the Evidence: Statistics for Diagnosis.
TESTING A TEST Ian McDowell Department of Epidemiology & Community Medicine November, 2004.
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
TUTORIAL SCREENING Dr. Salwa Tayel, Dr. A. Almazam, Dr Afzal Mahmood
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
1 Comunicación y Gerencia 18/4/2011Dr Salwa Tayel (Screening) بسم الله الرحمن الرحيم.
Baye’s Rule and Medical Screening Tests. Baye’s Rule Baye’s Rule is used in medicine and epidemiology to calculate the probability that an individual.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Screening revision! By Ilona Blee. What are some UK Screening programmes?  Antenatal & newborn screening  Newborn Blood Spot  Newborn Hearing Screening.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
Screening Sherine Shawky, MD, Dr.PH Assistant Professor Public Health King Abdulaziz University College of Medicine
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
Diagnosis Concepts and Glossary. Cross-sectional study The observation of a defined population at a single point in time or time interval. Exposure and.
Multiple Choice Questions for discussion
Clinical Approach to Patients Tanarat Choon-ngarm MD.
Thomas B. Newman, MD, MPH Andi Marmor, MD, MSEd October 21, 2010.
Lecture 4: Assessing Diagnostic and Screening Tests
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
Dr K N Prasad Community Medicine
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
Scientific Method for a controlled experiment. Observation Previous data Previous results Previous conclusions.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Ann Jolly1 Screening “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...” “...sort.
Screening Puja Myles
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
SCREENING TTTThe search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy.
Principles of Screening
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
Positive Predictive Value and Negative Predictive Value
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Thomas B. Newman, MD, MPH Andi Marmor, MD, MSEd October 23, 2008.
Assist. Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine Class 2:
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
The Diagnostic Process A BRIEF OVERVIEW diagnostic process What is it? to figure out to problem solve method scheme.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
12/12/2009Dr. Salwa Tayel1 Comunicación y Gerencia.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Critical Appraisal Course for Emergency Medicine Trainees Module 5 Evaluation of a Diagnostic Test.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Cancer prevention and early detection
Clinical Epidemiology
Principles of Epidemiology E
Class session 7 Screening, validity, reliability
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
Comunicación y Gerencia
Chapter 7 The Hierarchy of Evidence
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Public Health Phase 3A Abigail Aitken
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Screening, Sensitivity, Specificity, and ROC curves
Dr. Hannah Jordan Lecturer in Public Health ScHARR
No matter what the type of genetic screening, certain core principles should be followed before a program is introduced. Principles of Screening • The.
Screening and Prevention
Evidence Based Diagnosis
Presentation transcript:

Principles and Predictive Value of Screening

Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity and positive predictive value Discuss how a clinician can make test results more meaningful to the client Explore factors that influence clinical interpretation and explain how to individualize them for each client

Screening Objective is to reduce mortality and morbidity with early detection Screening is the application of a test to people. It assist with early identification of a disease.

Principles of Good Screening Programs Screen for health problems that –Are important to the individual and community –Have an acceptable form of treatment –Has a natural history that is adequately understood –Has a recognizable latent or early symptomatic stage –Has a suitable screening test –Is economically beneficial

The Screening Test Ideally should be inexpensive, easy to administer (low risk) and with minimal discomfort There should be a Gold Standard based on the evidence Results should be accurate/valid and reliable/reproducible/precise

Accurate/Valid Defined as: The degree to which a variable actually represents what it is supposed to represent. Best way to assess –Compare with a reference Threatened by systematic error (bias) –Due to observer, subject and/or instrument

Reliable/Precise Defined as –The degree to which a variable has nearly the same value when measured several times Best way to assess –Repeated measures Threatened by random error –Due to observer, subject and/or instrument

Predictive Value Is determined by Sensitivity, Specificity and the Prevalence of the disease Prevalence is defined as the number of patients per 100,000 population who have the disease at a given time

Sensitivity The fraction of those with the disease correctly identified as positive by the test. Specificity The fraction of those without the disease correctly identified as negative by the test.

Positive predictive value (+ PV) The fraction of people with positive tests who actually have the condition. Negative predictive value (-PV) The fraction of people with negative tests who actually don't have the condition.

The sensitivity and specificity are properties of the test. The positive and negative predictive values are properties of both the test and the population you test. If you use a test in two populations with different disease prevalence, the predictive values will be different. A screening test is most useful if directed to a high-risk population (high prevalence and high predictive value).

How to remember Sensitivity: "I know my patient has the disease. What is the chance that the test will show that my patient has it?“ Specificity: "I know my patient doesn't have the disease. What is the chance that the test will show that my patient doesn't have it?"

Cont. +PV: “I just got a positive test result back on my patient. What is the chance that my patient actually has the disease?” -PV: “I just got a negative test result back on my patient. What is the chance that my patient actually doesn't have the disease?”

Now to the Math Patient with the disease Patient without the disease Test is positive A True Positive B False Positive Test is negative C False Negative D True Negative

Using the 2X2 table you can calculate Sensitivity = a / (a+c) Specificity = d / (b+d) + PV = a/(a+b) - PV = d/(c+d) Knowing the prevalence of the disease in the population is necessary for these calculations

Understanding Predictive Value Prevalence is defined as the number of patients per 100,000 population who have the disease at a given time. A high +PV indicates a strong chance that a person with a positive test has the disease whereas a low +PV is usually found in populations with low prevalence of the condition being examined. A high -PV means that a negative test in effect rules out the disease.

Effects of Prevalence Sensitivity=95% Specificity=95% Population’s Prevalence 0.1% 1.0% 2.0% 5.0% 50% Predictive Value of a Positive Test 1.9% 16.1% 27.9% 50% 95%

Effects of Prevalence Sensitivity=99% Specificity=99% Population’s Prevalence 0.1% 1.0% 2.0% 5.0% 50% Predictive Value of a Positive Test 9.0% 50% 66.9% 83.9% 99%

SpPins and SnNout SpPIn When a sign, test or symptom has an extremely high specificity (say, over 95%), a positive result tends to rule in the diagnosis. For example, the specificity of 3 or more positive responses on a CAGE questionnaire in diagnosing alcoholism is >99% among internal medicine patients. Therefore, if a person does answer "yes" to 3 or 4 of the CAGE questions, it rules in the diagnosis of alcohol dependency. SnNOut When a sign, test or symptom has a high sensitivity, a negative result rules out the diagnosis. For example, the sensitivity of the loss of retinal vein pulsation in diagnosing high intracranial pressure is 100 per cent. Therefore, if a person displays retinal vein pulsation, it rules out important increases in intracranial pressure.

Website Reading 1.Testing a Test -1.html By, J A Muir Gray MD FRCP (Glas) MRCGP FFCM Director of Health Policy and Public Health 2. SpPins and SnNouts pPinsnNout.html

Suggested Assignment Guided discussion or an individual assignment about a specific screening –Exploring the natural history of the disease, the gold standard, different population (prevalence), and calculating specificity, sensitivity, +PV and –PV –Debating the pro and cons of this screening as it relates to the Principles of Screening and Screening Test –Interpretation of results and relaying information to clients

The End This presentation was created by: Mary Beth Bigley, DrPH-c, ANP Assistant Professor Director of the Nurse Practitioner Program The George Washington University You are welcome to contact me to discuss the use of this material and additional learning activities.